Atlas Trials

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Clinical trial NCT00748215 · COMPLETED

Trial details

NCT number
NCT00748215
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapeutic Agent ToxicityColorectal CancerDiarrhea
Start date
2009-02-04
Primary completion
2014-08-12
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.